The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice

被引:21
作者
Borjesson, Anna E. [1 ]
Farman, Helen H. [1 ]
Engdahl, Cecilia [1 ]
Koskela, Antti [2 ]
Sjogren, Klara [1 ]
Kindblom, Jenny M. [1 ]
Stubelius, Alexandra [1 ]
Islander, Ulrika [1 ]
Carlsten, Hans [1 ]
Antal, Maria Cristina [3 ]
Krust, Andree [3 ]
Chambon, Pierre [3 ]
Tuukkanen, Juha [2 ]
Lagerquist, Marie K. [1 ]
Windahl, Sara H. [1 ]
Ohlsson, Claes [1 ]
机构
[1] Univ Gothenburg, Ctr Bone & Arthrit Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden
[2] Univ Oulu, Dept Anat & Cell Biol, Oulu, Finland
[3] Univ Strasbourg UdS, Dept Funct Genom, IGBMC, Coll France, Illkirch Graffenstaden, France
基金
瑞典研究理事会;
关键词
ESTROGEN RECEPTOR; BONE; TRABECULAR; CORTICAL; SERM; BONE-MINERAL DENSITY; TRANSCRIPTIONAL ACTIVATION; POSTMENOPAUSAL WOMEN; TRABECULAR BONE; CORTICAL BONE; FRACTURE RISK; SEX STEROIDS; ER-ALPHA; RALOXIFENE; IDENTIFICATION;
D O I
10.1002/jbmr.1842
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estradiol (E2) is important for male skeletal health and the effect of E2 is mediated via estrogen receptor (ER)-. This was demonstrated by the findings that men with an inactivating mutation in aromatase or a nonfunctional ER had osteopenia and continued longitudinal growth after sexual maturation. The aim of the present study was to evaluate the role of different domains of ER for the effects of E2 and selective estrogen receptor modulators (SERMs) on bone mass in males. Three mouse models lacking either ERAF-1 (ERAF-10), ERAF-2 (ERAF-20), or the total ER (ER/) were orchidectomized (orx) and treated with E2 or placebo. E2 treatment increased the trabecular and cortical bone mass and bone strength, whereas it reduced the thymus weight and bone marrow cellularity in orx wild type (WT) mice. These parameters did not respond to E2 treatment in orx ER/ or ERAF-20 mirx ERAF-10 mice were tissue-dependent, with a clear response in cortical bone parameters and bone marrow cellularity, but no response in trabecular bone. To determine the role of ERAF-1 for the effects of SERMs, we treated orx WT and ERAF-10 mice with raloxifene (Ral), lasofoxifene (Las), bazedoxifene (Bza), or vehicle. These SERMs increased total body areal bone mineral density (BMD) and trabecular volumetric BMD to a similar extent in orx WT mice. Furthermore, only Las increased cortical thickness significantly and only Bza increased bone strength significantly. However, all SERMs showed a tendency toward increased cortical bone parameters. Importantly, all SERM effects were absent in the orx ERAF-10 mice. In conclusion, ERAF-2 is required for the estrogenic effects on all evaluated parameters, whereas the role of ERAF-1 is tissue-specific. All evaluated effects of Ral, Las and Bza are dependent on a functional ERAF-1. Our findings might contribute to the development of bone-specific SERMs in males. (c) 2013 American Society for Bone and Mineral Research.
引用
收藏
页码:1117 / 1126
页数:10
相关论文
共 52 条
  • [1] ROLE OF THE 2 ACTIVATING DOMAINS OF THE ESTROGEN-RECEPTOR IN THE CELL-TYPE AND PROMOTER-CONTEXT DEPENDENT AGONISTIC ACTIVITY OF THE ANTIESTROGEN 4-HYDROXYTAMOXIFEN
    BERRY, M
    METZGER, D
    CHAMBON, P
    [J]. EMBO JOURNAL, 1990, 9 (09) : 2811 - 2818
  • [2] Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing
    Billon-Gales, Audrey
    Krust, Andree
    Fontaine, Coralie
    Abot, Anne
    Flouriot, Gilles
    Toutain, Celine
    Berges, Hortense
    Gadeau, Alain-Pierre
    Lenfant, Francoise
    Gourdy, Pierre
    Chambon, Pierre
    Arnal, Jean-Francois
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (32) : 13311 - 13316
  • [3] The transactivating function 1 of estrogen receptor α is dispensable for the vasculoprotective actions of 17β-estradiol
    Billon-Gales, Audrey
    Fontaine, Coralie
    Filipe, Cedric
    Douin-Echinard, Victorine
    Fouque, Marie-Jose
    Flouriot, Gilles
    Gourdy, Pierre
    Lenfant, Francoise
    Laurell, Henrik
    Krust, Andree
    Chambon, Pierre
    Arnal, Jean-Francois
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (06) : 2053 - 2058
  • [4] Roles of transactivating functions 1 and 2 of estrogen receptor-α in bone
    Borjesson, A. E.
    Windahl, S. H.
    Lagerquist, M. K.
    Engdahl, C.
    Frenkel, B.
    Moverare-Skrtic, S.
    Sjogren, K.
    Kindblom, J. M.
    Stubelius, A.
    Islander, U.
    Antal, M. C.
    Krust, A.
    Chambon, P.
    Ohlsson, C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (15) : 6288 - 6293
  • [5] Raloxifen prevents bone loss in castrated male mice
    Broulik, P. D.
    Broulikova, K.
    [J]. PHYSIOLOGICAL RESEARCH, 2007, 56 (04) : 443 - 447
  • [6] Molecular basis of agonism and antagonism in the oestrogen receptor
    Brzozowski, AM
    Pike, ACW
    Dauter, Z
    Hubbard, RE
    Bonn, T
    Engstrom, O
    Ohman, L
    Greene, GL
    Gustafsson, JA
    Carlquist, M
    [J]. NATURE, 1997, 389 (6652) : 753 - 758
  • [7] Effect of testosterone and estradiol in a man with aromatase deficiency
    Carani, C
    Qin, K
    Simoni, M
    FaustiniFustini, M
    Serpente, S
    Boyd, J
    Korach, KS
    Simpson, ER
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (02) : 91 - 95
  • [8] The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial
    Cummings, SR
    Eckert, S
    Krueger, KA
    Grady, D
    Powles, TJ
    Cauley, JA
    Norton, L
    Nickelsen, T
    Bjarnason, NH
    Morrow, M
    Lippman, ME
    Black, D
    Glusman, JE
    Costa, A
    Jordan, VC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23): : 2189 - 2197
  • [9] Lasofoxifene in Postmenopausal Women with Osteoporosis
    Cummings, Steven R.
    Ensrud, Kristine
    Delmas, Pierre D.
    LaCroix, Andrea Z.
    Vukicevic, Slobodan
    Reid, David M.
    Goldstein, Steven
    Sriram, Usha
    Lee, Andy
    Thompson, John
    Armstrong, Roisin A.
    Thompson, David D.
    Powles, Trevor
    Zanchetta, Jose
    Kendler, David
    Neven, Patrick
    Eastell, Richard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (08) : 686 - 696
  • [10] IDENTIFICATION OF A CONSERVED REGION REQUIRED FOR HORMONE DEPENDENT TRANSCRIPTIONAL ACTIVATION BY STEROID-HORMONE RECEPTORS
    DANIELIAN, PS
    WHITE, R
    LEES, JA
    PARKER, MG
    [J]. EMBO JOURNAL, 1992, 11 (03) : 1025 - 1033